Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Irani

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
European Urology|May 4, 2010
Testosterone measurement in patients with prostate cancerClaude C Schulman, Jacques Irani, Juan Morote, et al.
International Urology and Nephrology|September 18, 2021
Pre-transplant morphometry by computed tomography scan and post-transplant dialysis risk in overweight or obese kidney transplant recipientsUgo Pinar, Arthur Mageau, Yohann Renard, et al.
World Journal of Urology|August 14, 2020
Surgical complications risk in obese and overweight recipients for kidney transplantation: a predictive morphometric model based on sarcopenia and vessel-to-skin distanceUgo Pinar, Xavier Rod, Arthur Mageau, et al.
Urologic Oncology|December 17, 2013
Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progressionCeline Debiais-Delpech, Julie Godet, Nathalie Pedretti, et al.
World Journal of Urology|November 21, 2008
Oncological risk of laparoscopic surgery in urothelial carcinomasMorgan Rouprêt, Gordon Smyth, Jacques Irani, et al.
Transplantation|April 1, 2014
Analysis of perfusates during hypothermic machine perfusion by NMR spectroscopy: a potential tool for predicting kidney graft outcomeDelphine Bon, Claire Billault, Billault Claire, et al.
Brachytherapy|March 25, 2022
Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapyManon Kissel, Arthur Pounou, Kanta Ka, et al.
World Journal of Urology|September 6, 2019
Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC)Clara Delcourt, Pierre Gemival, François Xavier Nouhaud, et al.
BJU International|September 3, 2011
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significanceHein van Poppel, Alexander Haese, Markus Graefen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 18, 2005
Papillary necrosis following segmental renal infarction: an unusual cause of early renal allograft dysfunctionEstelle Desport, Frank Bridoux, Ramzi Abou Ayache, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
European Urology|May 4, 2010
Testosterone measurement in patients with prostate cancerClaude C Schulman, Jacques Irani, Juan Morote, et al.
International Urology and Nephrology|September 18, 2021
Pre-transplant morphometry by computed tomography scan and post-transplant dialysis risk in overweight or obese kidney transplant recipientsUgo Pinar, Arthur Mageau, Yohann Renard, et al.
World Journal of Urology|August 14, 2020
Surgical complications risk in obese and overweight recipients for kidney transplantation: a predictive morphometric model based on sarcopenia and vessel-to-skin distanceUgo Pinar, Xavier Rod, Arthur Mageau, et al.
Urologic Oncology|December 17, 2013
Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progressionCeline Debiais-Delpech, Julie Godet, Nathalie Pedretti, et al.
World Journal of Urology|November 21, 2008
Oncological risk of laparoscopic surgery in urothelial carcinomasMorgan Rouprêt, Gordon Smyth, Jacques Irani, et al.
Transplantation|April 1, 2014
Analysis of perfusates during hypothermic machine perfusion by NMR spectroscopy: a potential tool for predicting kidney graft outcomeDelphine Bon, Claire Billault, Billault Claire, et al.
Brachytherapy|March 25, 2022
Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapyManon Kissel, Arthur Pounou, Kanta Ka, et al.
World Journal of Urology|September 6, 2019
Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC)Clara Delcourt, Pierre Gemival, François Xavier Nouhaud, et al.
BJU International|September 3, 2011
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significanceHein van Poppel, Alexander Haese, Markus Graefen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 18, 2005
Papillary necrosis following segmental renal infarction: an unusual cause of early renal allograft dysfunctionEstelle Desport, Frank Bridoux, Ramzi Abou Ayache, et al.
Pageof 12